Product Images Spiriva Respimat

This is a summary of clinical trial results comparing Spiriva Respimat to Placebo with 324 participants in the Spiriva group and 307 in the Placebo group. The graph appears to show the results of treatment for a certain condition over a period of weeks. The "means are adjusted for center, smoking status at entry and baseline value."*

This text appears to be a graph depicting the FEVI (forced expiratory volume in one second) response over time since drug administration for three different treatments - placebo, salmeterol and SPIRIVA RESPIMAT. The graph shows data points at the 0.4 hour, 3 hour and 1 hour mark, with lines connecting those points. The x-axis shows time since drug administration in hours, while the y-axis shows the FEVI response. The sample sizes for each treatment group are shown in parentheses.*

The text is describing the features of a mouthpiece device that has a dose-release button, safety catch, clear base, and a piercing element for two different cartridges called Aqua and Blue. These cartridges have different strengths, and the device is meant to be used by taking two puffs, once a day.*

This text is a product name or feature. It indicates a feature related to dosing, probably in medicine or chemical application, that is capable of measuring and indicating the amount or quantity.*

This text is a list of two different items and is not sufficient to provide a useful description.*

Spiriva Respimat is a tiotropium bromide inhalation spray. The package contents include each actuation delivers 25 meg and one Spiriva Respimat cartridge. The instructions state to insert the cartridge before use, and one dose is equal to two inhalations. The recommended dosage is 2.5 mcg/actuation, to be used once daily for oral inhalation only.*